STIM2 and breast carcinoma: It has been demonstrated that SOCE in estrogen receptor (ER)-positive breast cancer cells is mediated by Orai3 and STIM2/STIM1, whereas SOCE in ER-negative breast cancer cells mostly depends on the canonical Orai1/STIM1 pathway [51].